Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Learn which crypto basics are best for beginners, including safe asset types and simple purchasing strategies to get started.
24,671 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A major stake sale in Albertsons by a large hedge fund sparks questions about what insiders know and how it affects t...
A rising concentration in a handful of tech names is signaling a wall street flashing warning for many investors. Thi...
The stock market has surged on earnings and AI investments, but key policy and geopolitical risks loom. This guide ex...
So-Young's Q1 2026 results offer clues about growth momentum and profitability. This article breaks down the numbers,...
When a CFO sells company shares worth millions, investors naturally wonder what it means for stock risk and future re...
Palvella Therapeutics just saw a notable insider move after a multi-hundred percent rally. This guide breaks down the...
The AI hype loop is loud, but investors want results. This piece breaks down what mark zuckerberg admitted agents cou...
Memory chips power a growing digital world, from data centers to smartphones. As micron says memory chip supply could...
When a prominent hedge fund reports selling a large block of shares, it sparks questions about the stock’s future. Th...
Team (TISI) kicks off 2025 with a solid Q1 showing that blends growing customer demand with margin challenges. This a...
This article dives into EverCommerce (evcm) 2026 earnings, unpacking Q1 results, growth drivers, and the implications...